Incidence of WHO stage 3 and 4 conditions following initiation of Anti-Retroviral Therapy in resource limited settings

Curtis, Andrea J; Marshall, Catherine S; Spelman, Tim; Greig, Jane; Elliot, Julian H; Shanks, Leslie; Du Cros, Philipp; Casas, Esther C; Da Fonseca, Marcio Silveria; O'Brien, Daniel P

research

oai:fieldresearch.msf.org:10144/278997

Incidence of WHO stage 3 and 4 conditions following initiation of Anti-Retroviral Therapy in resource limited settings

Authors: Andrea J Curtis
Catherine S Marshall
Tim Spelman
Jane Greig
Julian H Elliot
Leslie Shanks
Philipp Du Cros
Esther C Casas
Marcio Silveria Da Fonseca
Daniel P O'Brien
Publication date: 2012
Publisher
Doi: DOI:10.1371/journal.pone.0052019

Abstract

To determine the incidence of WHO clinical stage 3 and 4 conditions during early anti-retroviral therapy (ART) in resource limited settings (RLS)

Similar works

Full text

Open in the Core reader

Download PDF

MSF Field Research

Provided a free PDF

oai:fieldresearch.msf....Last time updated on 6/20/2013View original full text link

This paper was published in MSF Field Research.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.